Evaluation of the Safety and Immunogenicity of Two Antigen Concentrations of the Mtb72F/AS02(A) Candidate Tuberculosis Vaccine in Purified Protein Derivative-Negative Adults

Tuberculosis (TB) remains a major cause of illness and death worldwide, making a new TB vaccine an urgent public health priority. Purified protein derivative (PPD)-negative adults (n = 50) were equally randomized to receive 3 doses at 1-month intervals (at 0, 1, and 2 months) of one of the following...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Leroux-Roels, Isabel, Leroux-Roels, Geert, Ofori-Anyinam, Opokua, Moris, Philippe, De Kock, Els, Clement, Frédéric, Dubois, Marie-Claude, Koutsoukos, Marguerite, Demoitié, Marie-Ange, Cohen, Joe, Ballou, W. Ripley
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology (ASM) 2010
Konular:
Vaccine Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2976103/
https://ncbi.nlm.nih.gov/pubmed/20861328
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/CVI.00133-10
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller